First RSV vaccine for people over 60 and pregnant women

Pregnant women can now protect their babies under 6 months of age from bronchiolitis and other respiratory diseases by being vaccinated between 24 and 36 weeks of pregnancy with the first adult serum that has just been approved by the Ministry of Health against respiratory syncytial virus. (RSV), which causes bronchiolitis. Pfizer’s bivalent prefusion protein F (RSVpreF) vaccine is also indicated for people over 60, but for now the NHS will only fund it for pregnant women, Pfizer’s medical director explained at the drug launch. Jose Chavez Company.

Pending guidelines yet to be set by the Public Health Commission, which must now decide whether to include it in the lifelong vaccination schedule, Abrysvo, the commercial name of the vaccine, consists of a single dose that is injected into the upper arm muscle. Since October, newborns have been immunized with nirsevimab, a monoclonal antibody rather than a vaccine, dramatically reducing hospitalization rates for RSV, the second cause of death in children under 12 months of age. This virus causes between 7,000 and 14,000 hospitalizations per year.